Manufacturing A World of Wellness
Global expertise in product development; producing quality, affordable pharmaceutical and healthcare products.
PuraCap International develops & markets prescription generic medications to meet patient needs for quality, efficacy and affordable products. PuraCap International is compromised of PuraCap Laboratories and PuraCab Caribe.
Our over the counter (OTC) business, Puravation Pharmaceuticals provides many top quality, OTC store brand &
private label products.
With our turn-key services, we can develop Prescription and OTC soft gelatin capsules in our state of the art facility, designed and constructed in accordance with all US FDA cGMP regulatory guidances.
Site Map
© 2024 PuraCap® Pharmaceutical LLC
All Rights Reserved.
This site is only intended for residents of the United States. The products discussed on this website may have different labeling in different countries
PuraCap® Pharmaceutical LLC,
100 Somerset Corp Blvd, Ste 3000
Bridgewater, NJ 08807
Phone: 908.941.5456
Fax: 908.941.5457
Manufacturing A World of Wellness
Global expertise in product development; producing quality, affordable pharmaceutical and healthcare products.
Click here to join our community
homeHOME
All PuraCap Pharmaceutical prescription
brand products meet our rigorous standards
for quality, accessibility and ease of therapeutic delivery.
PuraCap International develops & markets prescription generic medications to meet patient needs for quality, efficacy and affordable products. PuraCap International is compromised of PuraCap Laboratories and PuraCab Caribe.
Our over the counter (OTC) business, Puravation Pharmaceuticals provides many top quality, OTC store brand &
private label products.
With our turn-key services, we can develop Prescription and OTC soft gelatin capsules in our state of the art facility, designed and constructed in accordance with all US FDA cGMP regulatory guidances.
November 16, 2015
South Plainfield, NJ– November 3, 2015 – PuraCap Pharmaceutical LLC
announced today the introduction of a
new product, EpiCeram-L™ Lip Care,
a unique lip care formulation with an
exclusive delivery
July 10, 2014
PuraCap™ Pharmaceutical Introduces
Unique EpiCeram® 225g Airless Pump
EpiCeram® Controlled Release Skin
Barrier Emulsion Now Offers Dosing
Flexibility with 2 Sizes.
July 17, 2016
Piscataway, NJ– Humanwell Puracap Pharmaceuticals (Wuhan) Co., Ltd was introduced on Phoenix TV and Wuhan Television show “Manufacturing Pioneer”. The show tells the story behind the successful FDA inspection of Humanwell Puracap Pharmaceuticals.
November 13, 2015
Piscataway, NJ–November 11, 2015 – PuraCap Pharmaceutical LLC. is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection of its affiliated
Site Map
© 2024 PuraCap® Pharmaceutical LLC
All Rights Reserved.
This site is only intended for residents of the United States. The products discussed on this website may have different labeling in different countries
PuraCap® Pharmaceutical LLC,
100 Somerset Corp Blvd, Ste 3000
Bridgewater, NJ 08807
Phone: 908.941.5456
Fax: 908.941.5457
Read about the US news & events that move PuraCap® Pharmaceutical forward.
PuraCap® News from our state-of-the-art manufacturing facilities, which is our affiliate company Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. located at Wuhan, China.
PuraCap® Pharmaceutical LLC introduces new EpiCeram-L™ Lip Care
PuraCap® Pharmaceutical LLC introduces new EpiCeram-L™ Lip Care
Humanwell Puracap Pharmaceuticals (Wuhan) Co., Ltd was introduced on Phoenix TV and Wuhan Television show
HumanWell PuraCap Pharmaceuticals Announces Successful FDA Inspection
March 30, 2016
Piscataway, NJ – Humanwell Healthcare Group and PuraCap® Pharmaceutical LLC announced today that the companies have entered into a definitive agreement to acquire 100% of the membership interests of Epic Pharma, LLC of Laurelton, NY for $550 million. The acquisition will further establish Humanwell and PuraCap in the US generics market and expand their existing commercial and manufacturing capabilities.